Amanta Healthcare Ipo
Objects of the Issue
Funding capital expenditure requirements for civil construction work and towards purchase of equipment, plant and machinery for setting up new manufacturing line of SteriPort at Hariyala, Kheda, Gujarat
Funding capital expenditure requirements towards civil construction work, purchase of equipment, plant and machinery for setting up new manufacturing line for SVP at Hariyala, Kheda, Gujarat
General Corporate Purposes
Amanta Healthcare IPO Review
IPO Watch: May Apply
Invest4Edu Private Limited: Apply
Scoop Investment: May Apply
Exencial Research Partners: May Apply
Minerva Capital Research Solutions: May Apply
Capital Market: Avoid
IPO Lead Managers aka Merchant Bankers
Beeline Capital Advisors Pvt Ltd.
Application | Lot Size | Shares | Amount |
Retail Minimum | 1 | 119 | ₹14,994 |
Retail Maximum | 13 | 1,547 | ₹1,94,922 |
S-HNI Minimum | 14 | 1,666 | ₹2,09,916 |
B-HNI Minimum | 67 | 7,973 | ₹10,04,598 |
IPO Open Date: | September 1, 2025 |
IPO Close Date: | September 3, 2025 |
Basis of Allotment: | September 4, 2025 |
Refunds: | September 5, 2025 |
Credit to Demat Account: | September 5, 2025 |
IPO Listing Date: | September 8, 2025 |
Period Ended | Revenue | Expense | PAT | Assets |
2023 | ₹263 | ₹206 | ₹2.11 | ₹374 |
2024 | ₹282 | ₹223 | ₹3.63 | ₹352 |
2025 | ₹276 | ₹215 | ₹10.50 | ₹382 |
KPI | Values |
ROE: | 12.42% |
ROCE: | 13.72% |
EBITDA Margin: | 22.11% |
PAT Margin: | 3.86% |
Debt to equity ratio: | 2.02 |
Earning Per Share (EPS): | ₹3.71 (Basic) |
Price/Earning P/E Ratio: | N/A |
Return on Net Worth (RoNW): | 10.89% |
Net Asset Value (NAV): | ₹33.43 |
Company | EPS | PE Ratio | RoNW % | NAV | Income |
Denis Chem Lab Limited | 5.82 | 15.92 | 9.49% | 61.33 | 176 Cr. |
IPO Open Date: | September 1, 2025 |
IPO Close Date: | September 3, 2025 |
Face Value: | ₹10 Per Equity Share |
IPO Price Band: | ₹120 to ₹126 Per Share |
Issue Size: | Approx ₹126 Crores |
Fresh Issue: | Approx ₹126 Crores |
Lot Size: | 119 Shares |
Issue Type: | Book Built Issue |
IPO Listing: | BSE & NSE |
Retail Quota: | Not more than 35% |
QIB Quota: | Not more than 50% |
NII Quota: | Not more than 15% |
DRHP Draft Prospectus: | Click Here |
RHP Draft Prospectus: | Click Here |
Anchor Investors List: | Click Here |